You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
美藥廠艾伯維(ABBV.US)料第四季肉毒桿菌美容市佔率維持強勁
美國藥廠艾伯維 AbbVie (ABBV.US)周三表示,雖然競爭對手最近推出更長效的產品,但公司仍預計第四季度其Botox產品在美容市場的份額將保持強勁。 艾伯維首席商務官Jeffrey Stewart在摩根大通醫療保健會議上預期,將保持約68%的領先市場份額。 由於經濟不確定性,特別是美容用途的肉毒桿菌,在過去幾個季度一直面臨壓力,艾伯維投資者亦擔心,來自Revance Therapeutics(RVNC.US)、Evolus(EOLS.US)等新競爭對手的競爭,其產品面臨著市場份額被侵蝕的問題。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account